2014
DOI: 10.4172/0974-8369.1000e105
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial tRNA Modification Enzymes: Potential Role in Biology and Virulence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Interestingly, most of the common 44 genes required for in vitro and in vivo (enteric and systemic infection) fitness have been implicated in vaccine or drug target development against a broad spectrum of bacteria; for example, ATP synthase genes ( 87 , 89 ), dam ( 99 , 100 ), pstB ( 100 ), phoQ ( 101 ), ompR ( 102 ), xerC ( 103 ), and rfbBPN ( 104 ), manA ( 105 ), rpe ( 106 ), lepA ( 107 ), csgF ( 108 ), trmE ( 109 ), and SPI-1 and SPI-2 ( 110 ) have been used in vaccine development or drug target development ( Table 1 ). Thus, there lies a great potential to explore genes marBCT , envF , barA , hscA , rfaQ , rfbI , and putative proteins STM14_1138, STM14_3334, STM14_4825, and STM_5184 as novel therapeutic and intervention strategies to curb Salmonella infection.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, most of the common 44 genes required for in vitro and in vivo (enteric and systemic infection) fitness have been implicated in vaccine or drug target development against a broad spectrum of bacteria; for example, ATP synthase genes ( 87 , 89 ), dam ( 99 , 100 ), pstB ( 100 ), phoQ ( 101 ), ompR ( 102 ), xerC ( 103 ), and rfbBPN ( 104 ), manA ( 105 ), rpe ( 106 ), lepA ( 107 ), csgF ( 108 ), trmE ( 109 ), and SPI-1 and SPI-2 ( 110 ) have been used in vaccine development or drug target development ( Table 1 ). Thus, there lies a great potential to explore genes marBCT , envF , barA , hscA , rfaQ , rfbI , and putative proteins STM14_1138, STM14_3334, STM14_4825, and STM_5184 as novel therapeutic and intervention strategies to curb Salmonella infection.…”
Section: Discussionmentioning
confidence: 99%